Opti-MEM I Reduced Serum Medium, 100 mL and 8 more items

The University of Virginia awarded contract A207_PO-0449327 to Life Technologies Corporation on June 16, 2026, for a cumulative value of $2,797.46. The contract deliverables are directed to Brandon K. Davidson and consist of specialized laboratory supplies and reagents for cell culture and protein analysis applications. Life Technologies Corporation, as the prime contractor, is supplying nine distinct line items encompassing culture media, serum products, enzymatic reagents, and laboratory consumables necessary for biological research operations.

The product categories include cell culture media and additives such as Opti-MEM I Reduced Serum Medium and Fetal Bovine Serum, enzymatic solutions including Trypsin-EDTA and TrypLE Express Enzyme, laboratory equipment such as Nunc Multidish tissue culture plates and serological pipettes, and water purification components including a CO₂ Adsorber with sterile filter and a Reverse Osmosis Cartridge. Additionally, the contract encompasses a Pierce BCA Protein Assay Reagent A for protein quantification purposes. These materials support standard laboratory protocols employed in cell biology research and are typical of procurement requirements for university research facilities in Virginia.